Breaking News
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

image_pdfDownload PDFimage_print
Credit: Virginia Commonwealth University

Ninety percent of adults in the U.S. with an Alcohol Use Disorder don’t get treatment, according to the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. To help make treatment more accessible, the NIH recently launched an online Alcohol Treatment Navigator, which gives providers and AUD patients information on evidence-based treatment options. The site also offers a brief survey to help a potential patient determine the range or severity of a problem.

Meeting patients where they are and then drawing them to the services that are most beneficial is the avenue by which more people will receive treatment and more AUD treatments will be developed, said Dace Svikis, Ph.D., a professor in the Virginia Commonwealth University Departments of Psychology and Psychiatry and the VCU Health Department of Obstetrics and Gynecology. Svikis is currently working on several projects researching the effects of alcohol, modernized treatments and appropriately diagnosing AUD.

VCU and VCU Health are home to several programs to help varying demographics cope with AUD, including the multidisciplinary Alcohol Research Center, which focuses on preclinical and clinical studies to identify the root cause of alcohol misuse and alcoholism. Tools such as the NIAAA’s Alcohol Treatment Navigator modernize how patients are treated and revolutionize how treatment is offered and administered, Svikis said.

VCU News recently talked with Svikis to learn how VCU and VCU Health are helping patients by making sure treatment is accessible to anyone in need.

How has alcoholism traditionally been diagnosed?

Traditionally, AUD, commonly referred to as alcoholism, is diagnosed when there is a problematic pattern of drinking that leads to clinically significant impairment or distress. To make a diagnosis, a trained clinician typically interviews the person about his or her drinking. The interviewer looks for evidence of several things:

  • Impaired control or drinking more than intended
  • Social impairment, such as conflicts with friends as a result of drinking or driving or operating machinery while inebriated
  • Physical impairment

In what way has alcoholism traditionally been treated?

Historically, alcoholism treatment was associated with either long-term residential treatment or Alcoholics Anonymous. Since that time, the menu of treatment options for AUD has expanded considerably. AUD treatment modalities range from inpatient medical detoxification to short- or long-term residential treatment, to various outpatient treatment options. Evidence-based behavioral treatments for AUD include brief intervention, typically delivered in medical care settings like an emergency department, as well as cognitive behavioral therapy, motivational enhancement therapy, contingency management and behavioral couples and family counseling among others. While less well-known, there are also three Food and Drug Administration-approved nonaddictive medications for AUD: naltrexone, acamprosate and disulfiram.

In your professional opinion, how potentially useful is a tool like the Alcohol Treatment Navigator?

It is often challenging for individuals with AUD to obtain accurate information about alcohol treatment options and different paths to recovery. The Alcohol Treatment Navigator provides easy-to-understand information about AUD as a chronic, relapsing disorder and the range of well-researched alcohol treatment options to consider. This tool also makes it easier to search for local treatment options and other recovery resources, with a toolkit of downloadable worksheets to guide individuals in their search for appropriate, quality care. In addition, this tool provides information and support resources to people living with AUD and their family members.

How can addiction and treatment professionals use this type of tool to benefit patients?

Across a variety of settings, the Alcohol Treatment Navigator is something health care providers can make available to patients who report alcohol problems and are looking for the best local treatment options. It also can educate interested professionals about AUD and increase awareness about the range of evidence-based treatment options that exist in this country.

What recent studies has VCU been part of regarding the treatment of alcoholism?

VCU is involved in a variety of projects focused on the identification and treatment of heavy and problem drinking. One longstanding commitment is to community-based research through the National Institute on Drug Abuse Clinical Trials Network. In collaboration with Johns Hopkins University and Friends Research Institute, VCU represents the Mid-Atlantic branch of CTN.

Over the last 15 years, VCU researchers have contributed to several multi-site national studies of interventions such as motivational interviewing, medication-assisted treatment, and even an employment-focused intervention to improve outcomes in treatment. More recently, Lauretta Cathers, Ph.D., a faculty member in the Department of Rehabilitation Counseling in the School of Allied Health Professions, and I participated in a multi-site CTN study of the Tobacco, Alcohol, Prescription medication, and other Substance use measure—TAPS. The purpose of the study was to develop and test TAPS as a tool that could address the need for a brief screening and assessment instrument that would not only include all commonly used substances, but also could be implemented in routine clinical practice.

Is diagnosing alcoholism on a full spectrum a new concept or something you’ve recognized throughout your career?

Early in my career, I was taught that physical dependence on alcohol was an important factor in determining alcoholism severity. Particularly, it was important to assess the need for hospitalization, with medical management of the detoxification process. Subsequently, two diagnostic options were made available, with alcohol abuse generally considered less severe than alcohol dependence.

There is now a single diagnostic category, Alcohol Use Disorder, with several symptoms determining severity for any given individual. This single continuum and the labelling of severity by number of symptoms will likely make it a more salient variable in both clinical care and future research. At least two symptoms must be present to make a diagnosis, whereby more symptoms indicate greater severity. Symptom severity ranges from mild, two to three symptoms, to moderate, four to five symptoms. More than six symptoms indicates a severe problem.

What specific programs are in place at VCU (including referral programs) to treat and counsel people and families battling Alcohol Use Disorder?

Within VCU Health, hospitalized patients with AUD receive consultative services that include assessment, brief intervention and, when appropriate, referral to treatment. Many outpatient clinics at VCU routinely screen their patients to identify those at risk for problem drinking. Those identified, or who self-disclose an alcohol problem, also receive information about local treatment resources. Community Services Boards offer outpatient alcohol and other drug abuse treatment as well as mental health counseling and services. In the Richmond community, they include Richmond Behavioral Health Authority, Chesterfield Mental Health Support Services and Henrico Area Mental Health & Developmental Services.

VCU Health also has an outpatient facility, the MOTIVATE Clinic, established, in part, in response to the opioid epidemic. Many individuals who abuse opioids have comorbid conditions, including alcoholism, which is why this type of treatment is critical. For students, The Wellness Resource Center – The Well— is available. The Well offers a variety of individual- and peer-focused educational programs on early intervention for alcohol and other substance use disorders. Particularly noteworthy is our RAMS in Recovery program, which is a nationally recognized, confidential, community-based resource for students in recovery from alcohol and other drugs. Also, through the College Behavioral and Emotional Health Institute and Spit for Science, we have a universitywide program focused on the study of alcohol, and other drug use, and emotional health outcomes in college populations.


Explore further:
APA releases new practice guideline on treatment of alcohol use disorder

Provided by:
Virginia Commonwealth University

About author

Related Articles